Age | Atrial Fibrillation
Item
female and male subjects ≥ 18 years of age with a diagnosis of non-valvular atrial fibrillation
boolean
C0001779 (UMLS CUI [1])
C0004238 (UMLS CUI [2])
Treatment with Vitamin K antagonist | Problem Duration
Item
who are treated with vitamin k antagonists (vka) with issues for at least the 4 previous weeks (issues are assessed on medical judgment)
boolean
C1096489 (UMLS CUI [1])
C0033213 (UMLS CUI [2,1])
C0449238 (UMLS CUI [2,2])
rivaroxaban | Treatment Preventing Cerebrovascular accident | Treatment Preventing SYSTEMIC ARTERIAL EMBOLISM | Exception Central Nervous System
Item
who start treatment with rivaroxaban to prevent stroke or non-cns (central nervous system) systemic embolism
boolean
C1739768 (UMLS CUI [1])
C0087111 (UMLS CUI [2,1])
C1292733 (UMLS CUI [2,2])
C0038454 (UMLS CUI [2,3])
C0087111 (UMLS CUI [3,1])
C1292733 (UMLS CUI [3,2])
C0149876 (UMLS CUI [3,3])
C1705847 (UMLS CUI [4,1])
C3714787 (UMLS CUI [4,2])
Anticoagulation Therapy Planned
Item
with anticoagulation therapy planned for at least 6 months
boolean
C0003281 (UMLS CUI [1,1])
C1301732 (UMLS CUI [1,2])
Medical contraindication Xarelto
Item
contra indication to the use of xarelto as described in the summary of product characteristics (smpc); key contra indications are:
boolean
C1301624 (UMLS CUI [1,1])
C3159309 (UMLS CUI [1,2])
Hypersensitivity Xarelto | Hypersensitivity Xarelto Excipient
Item
hypersensitivity to the active substance or to any of the excipients listed in smpc section 6.1.
boolean
C0020517 (UMLS CUI [1,1])
C3159309 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C3159309 (UMLS CUI [2,2])
C0015237 (UMLS CUI [2,3])
Lesion At risk Hemorrhage Major | Condition At risk Hemorrhage Major
Item
lesion or condition at significant risk of major bleeding
boolean
C0221198 (UMLS CUI [1,1])
C1444641 (UMLS CUI [1,2])
C0019080 (UMLS CUI [1,3])
C0205164 (UMLS CUI [1,4])
C0348080 (UMLS CUI [2,1])
C1444641 (UMLS CUI [2,2])
C0019080 (UMLS CUI [2,3])
C0205164 (UMLS CUI [2,4])
Anticoagulants Other
Item
concomitant treatment with any other anticoagulant agent
boolean
C0003280 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
Hemorrhage
Item
clinically significant active bleeding
boolean
C0019080 (UMLS CUI [1])
Liver disease Associated with Blood Coagulation Disorders | Bleeding risk | Patients Cirrhotic Child-Pugh Classification
Item
hepatic disease associated with coagulopathy and clinically relevant bleeding risk including cirrhotic patients with child pugh b and c
boolean
C0023895 (UMLS CUI [1,1])
C0332281 (UMLS CUI [1,2])
C0005779 (UMLS CUI [1,3])
C3251812 (UMLS CUI [2])
C0030705 (UMLS CUI [3,1])
C0439686 (UMLS CUI [3,2])
C4050412 (UMLS CUI [3,3])
Pregnancy | Breast Feeding
Item
pregnancy and breast feeding
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])